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Abstract
Traditional models of future alcohol use in adolescents have used variable-centered approaches, predicting alcohol use
from a set of variables across entire samples or populations. Following the proposition that predictive factors may vary in
adolescents as a function of family history, we used a two-pronged approach by first defining clusters of familial risk,
followed by prediction analyses within each cluster. Thus, for the first time in adolescents, we tested whether adolescents
with a family history of drug abuse exhibit a set of predictors different from adolescents without a family history. We apply
this approach to a genetic risk score and individual differences in personality, cognition, behavior (risk-taking and
discounting) substance use behavior at age 14, life events, and functional brain imaging, to predict scores on the alcohol
use disorders identification test (AUDIT) at age 14 and 16 in a sample of adolescents (N= 1659 at baseline, N= 1327 at
follow-up) from the IMAGEN cohort, a longitudinal community-based cohort of adolescents. In the absence of familial risk
(n= 616), individual differences in baseline drinking, personality measures (extraversion, negative thinking), discounting
behaviors, life events, and ventral striatal activation during reward anticipation were significantly associated with future
AUDIT scores, while the overall model explained 22% of the variance in future AUDIT. In the presence of familial risk (n=
711), drinking behavior at age 14, personality measures (extraversion, impulsivity), behavioral risk-taking, and life events
were significantly associated with future AUDIT scores, explaining 20.1% of the overall variance. Results suggest that
individual differences in personality, cognition, life events, brain function, and drinking behavior contribute differentially to
the prediction of future alcohol misuse. This approach may inform more individualized preventive interventions.
Introduction
Alcohol use disorder (AUD) is a complex psychiatric
condition that involves both genetic and environmental
factors. In adolescents, alcohol use is common with 10%
of 14-year-olds in the National Comorbidity Survey
reporting regular alcohol use, and up to 27% of the
American 16-year-olds reporting regular alcohol use1 and
up to 12% suffering from any type of substance use dis-
order2. In Europe, estimates of alcohol misuse (specifi-
cally, binge drinking) have been as high as 59% for 30-day
prevalence rates for 15–16-year-olds3. The development
of AUD in adolescence is one strong predictor for future
(adult) alcohol dependence4 which cannot be fully
explained by genetics5.
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Beyond early alcohol use4,5 the most consistently identi-
fied risk factors for adolescent alcohol misuse include
childhood adversity and other negative life events6, cogni-
tive dysfunction and impulsivity7–9, as well as early (peer)
deviance10,11. Genetic association studies have pointed to
polygenetic risk scores12,13. Additionally, a significant con-
tribution of familial risk to adolescent alcohol misuse has
long been proposed14–18. Parental AUD was shown to
predict the onset of hazardous alcohol use and alcohol
dependence in adolescents but not non-problematic
drinking18. Furthermore, next to genetic factors, neurobio-
logical reward-related mechanisms have been proposed as a
possible link between familial risk and alcohol misuse, but
empirical results showed that adolescents with familial risk
of alcohol misuse compared to adolescents without familial
risk showed no difference in reward-related activation in the
ventral striatum (VS)19. However, reward system activity
was increased in adult participants with a AUD family
history as compared to adults without family history20.
Recently, longitudinal analyses of incipient AUD in
adolescence have used more elaborate designs and/or
analyses to improve both the predictive power and
causal understanding of AUD development in adoles-
cents. For example, Kendler et al. have used different
groupings of longitudinal trajectories of consumption
patterns to study associations to genetic and behavioral
risk factors in adolescence11,21,22. Whelan et al. have
used machine learning approaches to validate neu-
ropsychological profiles of future alcohol misuse
including individual differences in personality and cog-
nition, substance use at age 14, life events, and func-
tional brain imaging23, yielding predictive validity with
precision rates as high as 91%.
Nees et al. were able to explain 17% of variance in early
onset of drinking in 14-year-old adolescents with a latent
factor for brain regions (0.4% variance), personality (16%
variance), and behavior (0.6% variance)8 in data from the
same cohort as the present study (IMAGEN). Parental
alcohol use, however, did not predict early onset of
drinking, therefore a role of parental AUD only at later
stages in adolescents was suggested. This finding is in line
with other findings, also from the IMAGEN cohort, where
candidate genetic variation only significantly added to
predicting alcohol drinking behavior in 16-year-old ado-
lescents, but not in 14-year-olds24. In early adolescence
(14 years) personality traits contributed to the main part
of the 13% explained variance of alcohol drinking beha-
vior, whereas genetic variations, reward-related brain
response, and behavior did not significantly predict ado-
lescent alcohol drinking. At age 16, personality and
genetic variation contributed to the 14% explained var-
iance in alcohol drinking.
Despite the precision achieved in prediction with large
amounts of variance explained using different sets of
longitudinal trajectories, the current approaches make it
difficult to predict and identify risk factors at an individual
or even subgroup level, since they either employ sets of
variables across cohorts (i.e., are variable-centered23) or
rely on future change of predictors themselves11,22.
Previous studies in young adults have shown that patients
with a family history of drug abuse may exhibit different sets
of predictors for alcohol and drug abuse as compared to
adults without a family history of drug abuse25. In adults with
a positive family history of drug abuse, especially impulsivity
and risk-taking behaviors have recently been associated with
increased and harmful alcohol use26. This relationship
between impulsivity and family history is further supported
by genetic analyses that propose impulsivity to be a
mechanistic mediator of familial risk for alcohol abuse27. At
the same time, in a prior analysis from the IMAGEN study,
there was no significant difference in ventral striatal activity
in adolescents with and without a family history of substance
abuse, suggesting that alterations in the reward system could
be independent of familial risk factors19. Therefore, there is a
likelihood that different predictor sets for alcohol use are at
work in adolescents with as compared to without a family
history of substance abuse. Here, we specifically tested for the
first time whether adolescents with a family history of drug
abuse exhibit a set of predictors different from adolescents
without a family history. Such patterns would not necessarily
imply that family history itself acts as a potent risk factor in
early adolescence, but that the effects of predictors may vary
as a function of family history.
One strategy to test for such effects would be to stratify
adolescents in groups according to baseline variables, e.g.
using latent class or other clustering approaches. Such an
approach would allow to test different predictive models
in different groups, i.e. hypotheses that risk profiles may
differ between groups of adolescents based on a pre-
defined stratification. In the present study, our primary
aim was to test the feasibility and predictive utility of such
an approach using data from the IMAGEN cohort23,28.
Given the potentially numerous interactions between
genetic and familial risk factors on the one hand, and
behavioral risk factors on the other, we decided to a priori
cluster subjects according to familial risk, and then test for
differences in predictive models within these familial risk
groups. While we could not state a clear a-priori hypoth-
esis based on interactions between genetic and behavioral
factors, we tentatively hypothesized that baseline drinking,
neurobiological alterations of the reward system and
candidate genetic risk would be salient predictors of future
alcohol abuse in adolescents with familial risk, while
individual differences in personality would be more pre-
dictive in adolescents without familial risk.
Thus, in the present study, we aimed to characterize
differential predictors of hazardous alcohol use in 16-
year-old adolescents with and without familial risk.
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Methods
Sample
We used a sample of 2240 adolescents from the multi-
center IMAGEN study28 with available data from neu-
ropsychological, imaging, and genetic assessments (see
Table 1). School-based recruitment at age 14 took place at
eight different sites in Germany, the United Kingdom,
France, and Ireland. Subjects ineligible for MRI-Scans
were excluded as well as adolescents suffering from serious
medical conditions (e.g. diabetes, rheumatologic diseases,
neurological disorders, or developmental conditions). We
used data from the first and second waves of IMAGEN. A
detailed description of the recruitment and assessment
procedures has been published elsewhere28. All local ethics
research committees approved the study in accordance
with the Declaration of Helsinki. Written informed con-
sent was obtained from the parent or guardian, and verbal
assent was obtained from the adolescent.
Measures
Functional imaging tasks
The IMAGEN task-related fMRI datasets were reana-
lyzed at the Neurospin (Paris). We used these reanalyzed
datasets for functional imaging tasks.
Subjects were scanned in 3T-MRI-Scanners from
different manufacturers (Bruker, General Electric, Philips,
and Siemens, see28). Functional data was acquired
using a gradient-echo-planar-imaging (epi) T2*-weighted
sequence (echo time 30ms, repetition time 2.2 s, flip angle
75°). 300 volumes for MID task and 444 volumes for Stop
Signal Task (SST) (see below) were obtained, each con-
sisting of 40 slices (2.4 mm thickness. 1 mm gap, voxel
size: 3.4 mm × 3.4 mm × 3.4 mm). Analyses were per-
formed using SPM12 (Wellcome Trust Centre for Neu-
roimaging). Individual fMRI-images were slice-time
corrected, spatially realigned, and normalized on the
Montreal Neurological Institute space using a custom epi
template, which was created on the mean of a 200 subjects
set. Finally, images were smoothed with a 5-mm Gaussian
filter.
For the first-level analyses, a general linear model was
individually computed with a design-matrix including the
experimental regressors (see below) as well as 21 addi-
tional movement regressors (3 translations, 3 rotations, 3
translations shifted 1 TR before, 3 translations shifted 1
TR later, and 9 additional regressors corresponding to the
long term effects of the movement).
Monetary Incentive Delay (MID) The Monetary Incen-
tive Delay (MID) task29 required participants to respond
after seeing a cue (250 ms) and a delay of 4–4.5 s (blank
screen) to a briefly presented target (250–400ms) by
pressing either a left-hand or right-hand button as
quickly as possible to indicating monitor appearing side.








Female N (%) 838 (50.5) 412 (47.6) 426 (53.7) 0.037
Age M ± SD 14.55 ± 0.43 14.52 ± 0.42 14.58 ± 0.44 0.004
SES M ± SD 17.86 ± 3.88 18.04 ± 3.87 17.66 ± 3.89 0.050
AUDIT baseline M ± SD 1.48 ± 2.52 1.62 ± 2.82 1.33 ± 2.12 0.022
Baseline drinking M ± SD 2.00 ± 1.72 2.06 ± 1.71 1.94 ± 1.72 0.170
Baseline smoking M ± SD 0.80 ± 1.62 0.75 ± 1.59 0.86 ± 1.66 0.156
FH alcohol median ± SD









FH drug median ± SD
















Female N (%) 690 (52.0) 348 (48.9) 342 (55.5) 0.017
Age M ± SD 16.48 ± 0.62 16.46 ± 0.64 16.51 ± 0.59 0.119
SES M ± SD 18.07 ± 3.72 18.20 ± 3.72 17.92 ± 3.73 0.173
AUDIT FU M ± SD 3.81 ± 3.47 4.03 ± 3.59 3.55 ± 3.31 0.011
SES socioeconomic status, AUDIT Alcohol Use Disorder Identification Test, FH family history, FU follow up, M mean, SD standard deviation.
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Participants scored points when responding while the
target was on the screen, whereas they did not receive
points in case they responded after disappearing of the
target. A trial onset cue reliably indicated target position
and gain condition. A triangle indicated no points, a one-
lined circle 2 points and a three-lined circle 10 points. For
the first-level analysis, experimental events were modeled
by convolving the canonical hemodynamic response
function with the onsets of the anticipation and feedback
(hit or miss) periods for each cue and feedback type as
well as button presses. Individual contrast images were
calculated for anticipation (large gain versus small gain)
and feedback phase (large gain versus no gain) in hit trials.
On the second level, these differential t-contrast images
were entered to one sample t-tests including scanning site
as covariate. Regions of interest (ROI) analyses were
conducted using literature-based ROIs of the functional
key nodes VS, insula, and ventromedial prefrontal cortex
(VMPFC)30.
Stop Signal Task (SST) The Stop Signal Task (SST31)
required participants to respond to visual go stimuli (left
or right arrow) but to withhold their motor response
when the go stimulus was followed unpredictably by a
stop signal (upward arrow). Task difficulty was individu-
ally adjusted using an algorithm which has been described
elsewhere32. The SST contained 400 go trials with a
stimulus duration of 1000ms and 80 stop trials with a
stimulus duration of 0–900ms in accordance to the
algorithm.
First-level analysis was conducted with the experimental
regressors stop successful, stop failure, and two types of
failures (button press too late and wrong direction). These
events were modeled by convolving the canonical
hemodynamic response function with the onsets of the
trial types. Consequently, individual differential t-contrast
images were conducted for successful stop trials versus
unsuccessful stop trials and taken to second-level analysis.
These t-contrast images were used for one sample t-tests
including scanning site as covariate. ROI analyses were
conducted for orbitofrontal cortex and right inferior
frontal gyrus (pars triangularis) as described in the
Anatomic Labeling brain atlas33. These ROI were of
particular interest, because previous research showed an
enhanced importance of these regions in adolescence
illicit substance use34.
Personality measures
Three instruments were used to assess personality: the
dimension extraversion of the 60-item neuroticism-
extraversion-openness five-factor inventory (NEO-PI-
R35); the hopelessness dimension from the Substance Use
Risk Profile Scale (SURPS), which assesses personality
traits that confer risk for substance misuse and psycho-
pathology36; impulsiveness was measured via the revised
Temperament and Character Inventory (TCI-R37).
Cognition and behavior
Participants completed of the Wechsler intelligence
scale for children WISC-IV, of which we included two
indices: perceptual reasoning index (PRI: block design,
picture concepts, matrix reasoning) and verbal compre-
hension index (VRI: similarities, vocabulary, information,
comprehension)38.
Delay discounting as the preference of smaller
immediate over delayed larger rewards was measured
using the Monetary-Choice Questionnaire39.
Participants completed a slightly modified version of the
Cambridge Gambling Task (CGT) from the Cambridge
Cognition Neuropsychological Test Automated Battery
for a measurement of risk-taking outside a learning
context.
Stressful life events
The life-events questionnaire (LEQ40) uses 39 items to
measure the lifetime occurrence and the perceived
desirability of stressful events. We included a sum score of
two domains that are relevant for vulnerability and pre-
diction of substance abuse: sexuality and deviance.
Demographics
The socioeconomic status score comprised the sum of
the following domains: parents’ education, family stress,
unemployment, financial difficulties, home inadequacy,
neighborhood, financial crisis, parents’ employment.
Genetics
We included single nucleotide polymorphisms (SNPs)
described in a review and a genome-wide association
study of alcohol dependence13,28. Of the 30 SNPs listed in
that review, the IMAGEN sample data contained 15 SNPS
that passed quality control, did not have a low minor allele
frequency (<5%) or a high genotyping failure rate (>5%),
and were not highly correlated (>0.21) with any other
available SNP. Genetic data were available on 1835 indi-
viduals. From these data, we calculated a genetic risk
score (SNP risk score) by summing up the 15 trait-
associated alleles across many genetic loci, weighted by
effect sizes estimated from a genome-wide association
study41.
Substance misuse measures
The European School Survey Project on Alcohol and
Drugs battery (ESPAD) was administered42. The primary
questions of interest were regarding lifetime alcohol use
and lifetime cigarette consumption. In addition, at base-
line (age 14) as well as at follow-up (age 16), we used the
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alcohol use disorders identification test (AUDIT43; self-
report version) score. The AUDIT is a 10-item screening
tool to assess alcohol consumption, drinking behaviors,
and alcohol-related problems. A score of 8 or more is
considered to indicate hazardous alcohol use.
Familial risk of substance misuse
Familial risk of drug and alcohol misuse was derived
from multiple measurements and categorized in “positive
family history” (score 2), “negative family history” (score 0),
and “intermediate family history” (score 1, neither positive
nor negative, see also19,23). To assess familial risk of illicit
drug and alcohol misuse, the following measurements
were used: the Michigan Alcohol Screening Test
(MAST44), a family history interview on substance misuse,
parent-administered AUDIT and the Drug Abuse
Screening Test (DAST45). An intermediate family history
of alcohol misuse or illicit drug use was classified when
parents showed elevated scores on MAST, DAST, or
AUDIT without clear indication for misuse or when
alcohol or illicit drug misuse was assessed for second
degree relatives. An intermediate family history of illicit
drug misuse was identified, when parents scored higher
on DAST or drug misuse was assessed for second degree
relatives or when family history of alcohol misuse was
positive.
Participant’s parents completed the Pregnancy and
Birth Questionnaire (PBQ, adapted from46) as self-report
measurement on gestational alcohol and cigarette expo-
sure. Scores were recoded into binary variables.
Data analysis
All analyses were performed using SPSS version 25. All
tests were performed two-sided.
Two-step Clustering
To group adolescents regarding their family history of
substance abuse, we conducted a Two-Step Cluster ana-
lysis (TSC) using family history of substance misuse
(alcohol and illicit drugs) as input variables. We compared
the resulting clusters regarding the family history vari-
ables by conducting Mann–Whitney U tests. This data
reduction approach was implemented in order to separate
participants according to familial risk, assessed by two
variables á three categories.
Multiple regression
We performed collinearity diagnostics for all regression
models by analyzing the Variance Inflation Factors and
the tolerance statistics, which did not reveal any multi-
collinearity in the reported models. Since there was evi-
dence for heteroskedasticity in AUDIT baseline scores,
we compared results from baseline regression models
with heteroscedasticity-consistent parameters for those
models.
Overall sample We conducted two multiple regression
analyses to predict hazardous drinking (AUDIT) at
baseline (14 years) and follow-up (16 years) in the overall
sample. Twenty-eight predictors were pre-defined as
described above.
AUDIT baseline (14 years) We conducted two separate
regression models to predict hazardous drinking at
baseline in two clusters using Bonferroni adjusted α-
levels of 0.025 to control for multiple testing.
AUDIT follow-up (16 years) Analogously, we con-
ducted two separate regression models to predict
hazardous drinking at follow-up in two clusters and
adjusted α-levels to 0.025.
Results
Two-step Clustering
The overall sample used for two-step cluster analysis
(N= 2240) comprised 50.4% female adolescents, with
mean age of 14.55 years (SD= 0.43). The two-step cluster
analysis revealed two clusters on the basis of two variables
for familial risk for alcohol and illicit drug misuse (cluster
1N= 1187, cluster 2N= 1048, and one outlier cluster
N= 5). Full data on other demographic variables and
defined predictors was available for a total N= 1659 at
baseline and N= 1327 at follow-up. Characteristics of all
subjects and clusters are shown in Table 1. Clusters
clearly separated according to substance misuse history in
that cluster 1 was characterized by a presence of familial
risk for alcohol or drug misuse (intermediate to positive
family history of drug or alcohol misuse), whereas parti-
cipants in Cluster 2 showed no such family history
(negative family history of alcohol and drug misuse). Both
variables for familial risk differed significantly between the
two clusters (FH-drug: p= 0.000, FH-alcohol: p= 0.000).
The silhouette coefficient of 0.9 indicates a good cohesion
and cluster separation. The ratio of cluster sizes is 1.13




As detailed in Table 2, in our overall sample (N= 1659
14-year-old adolescents) higher scores of hazardous
drinking (AUDIT) were predicted by higher occurrence of
sexual and deviant life events (LEQ, β= 0.119, CI=
0.071–0.167, p= 0.000), more hopelessness (SURPS, β=
0.104, CI= 0.057–0.151, p= 0.000), more extraversion
(NEO, β= 0.067, CI= 0.020–0.114, p= 0.006), more
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smoking (ESPAD lifetime use, β= 0.385, CI=
0.338–0.432, p= 0.000), familial risk of alcohol and drug
misuse (β=−0.050, CI=−0.093 to −0.007, p= 0.024),
and higher prenatal alcohol exposure (PBQ, β= 0.079,
CI= 0.035–0.123, p= 0.000). Heteroscedasticity-consistent
parameters revealed identical significant predictors.
Higher scores of hazardous drinking (AUDIT) 2 years
later (N= 1376 16-year-old adolescents) were predicted
by higher occurrence of sexual and deviant life events
(LEQ, β= 0.131, CI= 0.075–0.187, p= 0.000), more
hopelessness (SURPS, β= 0.061, CI= 0.007–0.115, p=
0.026), stronger impulsivity (TCI, β= 0.062, CI=
0.010–0.114, p= 0.021), more extraversion (NEO, β=
0.124, CI= 0.069–0.179, p= 0.000), riskier behavior
(CGT, β= 0.053, CI= 0.004–0.102, p= 035), more
smoking and drinking at baseline (ESPAD lifetime use,
β= 0.062, CI= 0.006–0.118, p= 0.032; β= 0.258, CI=
0.203–0.314, p= 0.000), stronger ventral striatal activa-
tion during reward anticipation (MID, β= 0.082, CI=
0.020–0.144, p= 0.010) and outcome processing (MID,
β= 0.079, CI= 0.020–0.138, p= 0.009), weaker ven-
tromedial prefrontal activation during reward anticipation
(MID, β=−0.086, CI=−0.141 to −0.031, p= 0.002),
and weaker insula activation during outcome processing
(MID, β=−0.057, CI=−0.112 to −0.002, p= 0.042).
Prediction of AUDIT scores at baseline as a function of
familial risk
As detailed in Table 3, higher scores of hazardous
drinking in 14-year-old adolescents with familial risk for
Table 2 Prediction of AUDIT at baseline and follow-up in the overall sample.
AUDIT baseline (14 years) N= 1659 AUDIT follow-up (16 years) N= 1327
Variables Standardized beta p Standardized beta p
LEQ (sexuality, deviance) 0.119 (0.071–0.167) 0.000 0.131 (0.075–0.187) 0.000
SURPS hopelessness 0.103 (0.057–0.151) 0.000 0.061 (0.007–0.115) 0.026
MCQ discounting 0.030 (−0.014–0.074) 0.182 −0.035 (−0.085–0.015) 0.169
TCI impulsivity 0.019 (−0.027–0.065) 0.420 0.062 (0.010–0.114) 0.021
NEO extraversion 0.067 (0.020–0.114) 0.006 0.124 (0.069–0.179) 0.000
WISC-IV PRI −0.035 (−0.088–0.012) 0.161 −0.025 (−0.083–0.033) 0.380
WISC-IV VCI 0.014 (−0.042–0.077) 0.584 0.031 (−0.023–0.085) 0.282
CGT risk-taking −0.002 (−0.042–0.038) 0.923 0.053 (0.004–0.102) 0.035
SNP risk score 0.003 (−0.041–0.047) 0.894 −0.021 (−0.071–0.029) 0.408
SES −0.003 (−0.048–0.042) 0.905 0.012 (−0.043–0.068) 0.655
Baseline smoking 0.385 (0.338–0.432) 0.000 0.062 (0.006–0.118) 0.032
Baseline drinking – – 0.258 (0.203–0.314) 0.000
FH alcohol and drugs −0.050 (−0.093 to −0.007) 0.024 −0.058 (−0.098 to −0.002) 0.059
MID Insula anticipation −0.015 (−0.064–0.033) 0.543 −0.027 (−0.083–0.029) 0.344
MID VS anticipation 0.007 (−0.048–0.062) 0.805 0.082 (0.020–0.144) 0.010
MID VMPFC anticipation 0.008 (−0.039–0.055) 0.742 −0.086 (−0.141 to −0.031) 0.002
MID Insula outcome 0.019 (−0.029–0.068) 0.439 −0.057 (−0.112 to −0.002) 0.042
MID VS outcome −0.032 (−0.082–0.019) 0.217 0.079 (0.020–0.138) 0.009
MID VMPFC outcome −0.038 (−0.085–0.009) 0.118 −0.020 (−0.074–0.034) 0.466
SST OFC −0.004 (−0.068–0.060) 0.901 0.008 (−0.058–0.074) 0.811
SST rIFG −0.031 (−0.089–0.027) 0.298 0.022 (−0.047–0.091) 0.535
Prenatal cigarette consumption 0.008 (−0.035–0.051) 0.714 0.000 (−0.055–0.054) 0.986
Prenatal alcohol consumption 0.079 (0.035–0.123) 0.000 0.006 (−0.050–0.062) 0.834
AUDIT Alcohol Use Disorder Identification Test, LEQ Life Events Questionnaire, SURPS Substance Use Risk Profile Scale, TCI Temperament and Character Inventory, NEO
Revised NEO Personality Inventory—NEO PI-R, WISC-IV Wechsler Intelligence Scale for Children—Fourth Edition, PRI perceptual reasoning index, VCI verbal
comprehension index, CGT Cambridge Gambling Task, SNP single nucleotide polymorphisms, SES socioeconomic status, FH family history, MID Monetary Incentive
Delay, VS ventral striatum, VMPFC ventromedial prefrontal cortex, SST Stop Signal Task, OFC orbitofrontal cortex, rIFG right inferior frontal gyrus, AUDIT baseline R2=
0.244, AUDIT follow-up R2= 0.193.
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alcohol and drug abuse (N= 866) were predicted by
higher occurrence of sexual and deviant life events (LEQ,
β= 0.153, CI= 0.086–0.219, p= 0.000), more hope-
lessness (SURPS, β= 0.100, CI= 0.033–0.167, p= 0.003),
and more frequent lifetime smoking (ESPAD, β= 0.336,
CI= 0.271–0.401, p= 0.000). Heteroscedasticity-
consistent parameters additionally revealed extraversion
(p= 0.014) and prenatal alcohol consumption (p= 0.023)
as significant predictors of hazardous drinking.
Higher scores of hazardous drinking in 14-year-old
adolescents without familial risk of alcohol and drug
abuse (N= 793) were predicted by more hopelessness
(SURPS, β= 0.098, CI= 0.034–0.162, p= 0.003), more
smoking (ESPAD, β= 0.477, CI= 0.410–0.544, p=
0.000), stronger ventral striatal activation during reward
anticipation (MID, β= 0.103, CI= 0.028–0.174, p=
0.007), weaker ventromedial prefrontal activation during
outcome processing (MID, β=−0.093, CI=−0.160 to
−0.027, p= 0.006) and higher prenatal alcohol exposure
(PBQ, β= 0.098, CI= 0.038–0.157, p= 0.001).
Heteroscedasticity-consistent parameters revealed iden-
tical significant predictors.
Prediction of AUDIT scores at follow-up as a function of
familial risk
Higher scores of hazardous drinking 2 years later in 16-
year-old adolescents with familial risk for alcohol and
drug abuse (N= 711, see Table 4) were predicted by
higher occurrence of sexual and deviant life events (LEQ,
β= 0.129, CI= 0.052–0.198, p= 0.001), stronger impul-
sivity (TCI, β= 0.098, CI= 0.025–0.174, p= 0.009), more
extraversion (NEO, β= 0.117, CI= 0.039–0.189, p=
0.003), and more drinking at baseline (ESPAD, β= 0.234,
CI= 0.158–0.311, p= 0.000).
Table 3 Prediction of AUDIT scores at baseline as a function of familial risk.
Familial risk N= 866 No familial risk N= 793
Variables Standardized beta p Standardized beta p
LEQ (sexuality, deviance) 0.153 (0.086–0.219) 0.000 0.068 (−0.001–0.137) 0.054
SURPS hopelessness 0.100 (0.033–0.167) 0.003 0.098 (0.034–0.162) 0.003
MCQ discounting 0.047 (−0.014–0.108) 0.134 0.015 (−0.046–0.076) 0.632
TCI impulsivity 0.003 (−0.053–0.057) 0.931 0.045 (−0.017–0.107) 0.160
NEO extraversion 0.073 (0.004–0.142) 0.038 0.063 (0.002–0.128) 0.057
WISC-IV PRI −0.047 (−0.120–0.021) 0.177 −0.017 (−0.074–0.045) 0.617
WISC-IV VCI 0.002 (−0.058–0.058) 0.947 0.028 (−0.042–0.105) 0.419
CGT risk-taking 0.013 (−0.049–0.075) 0.682 −0.035 (−0.095–0.025) 0.252
SNP risk score −0.003 (−0.066–0.060) 0.926 0.019 (−0.041–0.079) 0.535
SES −0.010 (−0.069–0.050) 0.754 0.002 (−0.068–0.072) 0.948
Baseline smoking 0.336 (0.271–0.401) 0.000 0.477 (0.410–0.544) 0.000
MID Insula anticipation −0.027 (−0.097–0.043) 0.449 −0.014 (−0.082–0.054) 0.686
MID VS anticipation −0.051 (−0.127–0.025) 0.189 0.103 (0.028–0.178) 0.007
MID VMPFC anticipation 0.047 (−0.021–0.114) 0.172 −0.049 (−0.117–0.019) 0.157
MID Insula outcome 0.000 (−0.000–0.000) 0.998 0.048 (−0.015–0.111) 0.137
MID VS outcome −0.056 (−0.132–0.020) 0.147 −0.001 (−0.046–0.045) 0.969
MID VMPFC outcome 0.003 (−0.051–0.057) 0.920 −0.093 (−0.160 to −0.027) 0.006
SST OFC 0.011 (−0.074–0.096) 0.799 −0.009 (−0.083–0.065) 0.814
SST rIFG −0.023 (−0.106–0.060) 0.588 −0.057 (−0.136–0.022) 0.157
Prenatal cigarette consumption 0.018 (−0.046–0.082) 0.578 −0.029 (−0.080–0.042) 0.538
Prenatal alcohol consumption 0.069 (0.007–0.130) 0.028 0.098 (0.038–0.157) 0.001
AUDIT Alcohol Use Disorder Identification Test, LEQ Life Events Questionnaire, SURPS Substance Use Risk Profile Scale, TCI Temperament and Character Inventory, NEO
Revised NEO Personality Inventory—NEO PI-R, WISC-IV Wechsler Intelligence Scale for Children—Fourth Edition, PRI perceptual reasoning index, VCI verbal
comprehension index, CGT Cambridge Gambling Task, SNP single nucleotide polymorphisms, SES socioeconomic status, FH family history, MID Monetary Incentive
Delay, VS ventral striatum, VMPFC ventromedial prefrontal cortex, SST Stop Signal Task, OFC orbitofrontal cortex, rIFG right inferior frontal gyrus, familial risk R2= 0.224,
no familial risk R2= 0.315.
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Higher scores of hazardous drinking 2 years later in 16-
year-old adolescents without familial risk for alcohol and
drug abuse (N= 616) were predicted by higher occurrence
of sexual and deviant life events (LEQ, β= 0.151, CI=
0.067–0.236, p= 0.000), more hopelessness (SURPS, β=
0.090, CI= 0.012–0.175, p= 0.024), more extraversion
(NEO, β= 0.123, CI=−0.044–0.206, p= 0.002), more
drinking at baseline (ESPAD, β= 0.283, CI= 0.200–0.359,
p= 0.000), and stronger ventral striatal activation during
reward anticipation (MID, β= 0.132, CI= 0.042–0.222,
p= 0.004).
Discussion
The main aim of the present study was to characterize
differential predictors of hazardous alcohol use at age 14
and 16 in participants with and without familial risk.
Taken together, clustering by familial risk of alcohol and
illicit drug misuse and subsequent predictor analyses
revealed both overlapping and distinct predictor profiles
across the two groups. Hopelessness, smoking history, and
prenatal exposure to alcohol were associated with baseline
hazardous drinking in both groups, while life events only
contributed to baseline hazardous drinking in the presence
of familial risk only contributed in the absence of familial
risk. Subsequent hazardous drinking was predicted by life
events, extraversion, and baseline alcohol consumption in
both groups, while impulsivity (self-report via TCI-R) only
significantly predicted subsequent hazardous drinking in
the presence of familial risk. Analyses in the overall sample
also emphasize the role of familial risk, as it predicted
hazardous drinking at age 14 and closely missed sig-
nificance in predicting subsequent hazardous drinking.
Table 4 Prediction of AUDIT scores at follow-up as a function of familial risk.
Familial risk N= 711 No familial risk N= 616
Variables Standardized beta p Standardized beta p
LEQ (sexuality, deviance) 0.129 (0.052–0.198) 0.001 0.151 (0.067–0.236) 0.000
SURPS hopelessness 0.028 (−0.046–0.100) 0.461 0.090 (0.012–0.175) 0.024
MCQ discounting 0.006 (−0.066–0.077) 0.871 −0.083 (−0.1658 to −0.014) 0.031
TCI impulsivity 0.098 (0.025–0.174) 0.009 0.009 (−0.062–0.073) 0.812
NEO extraversion 0.117 (0.039–0.189) 0.003 0.123 (−0.044–0.206) 0.002
WISC-IV PRI 0.001 (−0.050–0.090) 0.970 −0.055 (−0.140–0.024) 0.186
WISC-IV VCI 0.034 (−0.045–0.108) 0.396 0.017 (−0.068–0.106) 0.674
CGT risk-taking 0.076 (0.007–0.–0.148) 0.030 0.035 (−0.038–0.113) 0.348
SNP risk score −0.054 (−0.123–0.011) 0.123 0.022 (−0.049–0.098) 0.544
SES 0.031 (−0.044–0.110) 0.418 −0.007 (−0.077–0.072) 0.854
Baseline smoking 0.074 (−0.004–0.155) 0.061 0.050 (−0.036–0.141) 0.253
Baseline drinking 0.234 (0.158–0.311) 0.000 0.283 (0.200–0.359) 0.000
MID Insula anticipation −0.026 (−0.105–0.053) 0.517 −0.030 (−0.114–0.054) 0.484
MID VS anticipation 0.046 (−0.043–0.–0.135) 0.311 0.132 (0.042–0.222) 0.004
MID VMPFC anticipation −0.078 (−0.154 to−0.002) 0.044 −0.092 (−0.174 to −0.010) 0.028
MID Insula outcome −0.062 (−0.140–0.016) 0.122 −0.047 (−0.126–0.032) 0.242
MID VS outcome 0.071 (−0.015–0.157) 0.105 0.082 (−0.002–0.166) 0.055
MID VMPFC outcome 0.001 (−0.051–0.053) 0.970 −0.034 (−0.114–0.046) 0.407
SST OFC 0.012 (−0.084–0.107) 0.896 −0.002 (−0.111–0.107) 0.973
SST rIFG 0.018 (−0.078–0.114) 0.713 0.026 (−0.073–0.125) 0.607
Prenatal cigarette consumption −0.043 (−0.116–0.029) 0.287 0.050 (−0.027–0.127) 0.202
Prenatal alcohol consumption 0.018 (−0.051–0.087) 0.664 −0.003 (−0.077–0.071) 0.937
AUDIT Alcohol Use Disorder Identification Test, LEQ Life Events Questionnaire, SURPS Substance Use Risk Profile Scale, TCI Temperament and Character Inventory, NEO
Revised NEO Personality Inventory—NEO PI-R, WISC-IV Wechsler Intelligence Scale for Children—Fourth Edition, PRI perceptual reasoning index, VCI verbal
comprehension index, CGT Cambridge Gambling Task, SNP single nucleotide polymorphisms, SES socioeconomic status, FH family history, MID Monetary Incentive
Delay, VS ventral striatum, VMPFC ventromedial prefrontal cortex, SST Stop Signal Task, OFC orbitofrontal cortex, rIFG right inferior frontal gyrus, familial risk R2= 0.192,
no familial risk R2= 0.214.
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These findings suggest that depressed mood, hazardous
behaviors, and significant life events strongly contribute to
early (in our sample, at age 14) hazardous alcohol use, while
subsequent use at age 16 is additionally influenced by
personality traits such as impulsivity and extraversion,
suggesting an effect of peer-related person-environment
interactions in adolescents’ development of drinking beha-
vior. At the same time, our findings are in line with recent
findings in older adults with a positive family history of drug
abuse26, we found impulsivity and risk-taking behaviors to
be sizeable predictors of increased and harmful alcohol use
in adolescents with a positive family history of drug abuse.
Thus, the effect of family history on alcohol use in adoles-
cents may be mediated by increased impulsivity and risk-
taking behavior in adolescents with familial risk.
Most notably, however, our results suggest that early
alterations in the reward system predict hazardous alcohol
use at both ages 14 and 16 in participants without familial
risk only. While this is in line with previous findings
showing no association between ventral striatal activation
and family history in adolescents19, the finding also sug-
gests that in adolescents without familial risk but
increased alcohol use, alterations in the reward system
may emerge or co-occur with increased alcohol use. Such
patterns have previously been shown for heavy drinkers in
late adolescence/early adulthood, and conspicuously did
not show any association with familial risk47. Therefore,
striatal alterations could have presented as marker for
increased alcohol use and hence increased risk in ado-
lescents without a family history of drug abuse.
Given that adult participants with a family history seem
to be more susceptible to hyperactive reward systems,
possibly in conjunction with altered levels of impulsivity20,
the finding of a differentially predictive effect of neuro-
biological alterations in the reward system at ages 14 and
16 in adolescents without a significant family history
suggests that, in the absence of familial risk, early hyper-
sensitivity of the reward system may be a strong moderator
of hazardous alcohol use. The effect sizes we find in this
sample suggest that alterations in the reward system may
account for roughly 2% of the variance in hazardous
drinking in adolescents, while overall models including all
predictor variables explained up to 22% of the variance.
Compared to previous studies, the comparably sizeable
amount of variance explained in our subcluster analyses
underlines the potential for subgroup or cluster-based, more
individualized prediction approaches for hazardous alcohol
use in adolescents. Results suggest that individual differences
in personality, cognition, life events, brain function, and
drinking behavior contribute differentially to the prediction
of future alcohol misuse. However, our key finding high-
lights that beyond personality and life event variables, in the
absence of familial risk, neurobiological alterations in ado-
lescents’ reward systems are directly associated with future
substance use disorder severity. This approach may inform
more individualized future preventive interventions.
Acknowledgements
This work received support from the following sources: the European Union-
funded FP6 Integrated Project IMAGEN (Reinforcement-related behavior in
normal brain function and psychopathology) (LSHM-CT-2007-037286), the
Horizon 2020 funded ERC Advanced Grant ‘STRATIFY’ (Brain network based
stratification of reinforcement-related disorders) (695313), ERANID
(Understanding the Interplay between Cultural, Biological and Subjective
Factors in Drug Use Pathways) (PR-ST-0416-10004), Human Brain Project (HBP
SGA 2, 785907, and HBP SGA 3, 945539), the Medical Research Council Grant ‘c-
VEDA’ (Consortium on Vulnerability to Externalizing Disorders and Addictions)
(MR/N000390/1), the National Institute of Health (NIH) (R01DA049238, A
decentralized macro and micro gene-by-environment interaction analysis of
substance use behavior and its brain biomarkers), the National Institute for
Health Research (NIHR) Biomedical Research Centre at South London and
Maudsley NHS Foundation Trust and King’s College London, the
Bundesministerium für Bildung und Forschung (BMBF grants 01GS08152;
01EV0711; FKZ 01EE1408E; Forschungsnetz AERIAL 01EE1406A, 01EE1406B,
01EE1406I), the Deutsche Forschungsgemeinschaft (DFG grants SM 80/7-2, SFB
940, TRR 265, NE 1383/14-1), the Medical Research Foundation and Medical
Research Council (grants MR/R00465X/1 and MR/S020306/1), the National
Institutes of Health (NIH) funded ENIGMA (grants 5U54EB020403-05 and
1R56AG058854-01). Further support was provided by grants from:—the ANR
(ANR-12-SAMA-0004, AAPG2019 - GeBra), the Eranet Neuron (AF12-NEUR0008-
01-WM2NA; and ANR-18-NEUR00002-01-ADORe), the Fondation de France
(00081242), the Fondation pour la Recherche Médicale (DPA20140629802), the
Mission Interministérielle de Lutte-contre-les-Drogues-et-les-Conduites-
Addictives (MILDECA), the Assistance-Publique-Hôpitaux-de-Paris and INSERM
(interface grant), Paris Sud University IDEX 2012, the Fondation de l’Avenir
(grant AP-RM-17-013), the Fédération pour la Recherche sur le Cerveau; the
National Institutes of Health, Science Foundation Ireland (16/ERCD/3797), U.S.A.
(Axon, Testosterone and Mental Health during Adolescence; RO1 MH085772-
01A1), and by NIH Consortium grant U54 EB020403, supported by a cross-NIH
alliance that funds Big Data to Knowledge Centres of Excellence.
Author details
1Social and Preventive Medicine, Department of Sports and Health Sciences,
Intra-faculty unit “Cognitive Sciences”, Faculty of Human Science, and Faculty
of Health Sciences Brandenburg, Research Area Services Research and e-
Health, University of Potsdam, Potsdam, Germany. 2Social, Genetic and
Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and
Neuroscience, King’s College London, London, UK. 3Department of Genetics
and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY,
USA. 4Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New
York, NY, USA. 5Department of Child and Adolescent Psychiatry and
Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim,
Heidelberg University, Square J5, 68159 Mannheim, Germany. 6Discipline of
Psychiatry, School of Medicine and Trinity College Institute of Neuroscience,
Trinity College Dublin, Dublin, Ireland. 7Centre for Population Neuroscience
and Precision Medicine (PONS), Institute of Psychiatry, Psychology &
Neuroscience, SGDP Centre, King’s College London, London, UK. 8Institute of
Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical
Faculty Mannheim, Heidelberg University, Square J5, Mannheim, Germany.
9Department of Psychology, School of Social Sciences, University of
Mannheim, 68131 Mannheim, Germany. 10NeuroSpin, CEA, Université Paris-
Saclay, F-91191 Gif-sur-Yvette, France. 11Departments of Psychiatry and
Psychology, University of Vermont, 05405 Burlington, VT, USA. 12Sir Peter
Mansfield Imaging Centre School of Physics and Astronomy, University of
Nottingham, University Park, Nottingham, UK. 13Physikalisch-Technische
Bundesanstalt (PTB), Braunschweig and Berlin, Berlin, Germany. 14Institut
National de la Santé et de la Recherche Médicale, INSERM U1299 “Trajectoires
développementales & psychiatrie”, University Paris Saclay, Ecole Normale
supérieure Paris-Saclay, CNRS, Centre Borelli, Gif-sur-Yvette, France. 15Institut
National de la Santé et de la Recherche Médicale, INSERM U1299 “Trajectoires
développementales & psychiatrie”, University Paris Saclay, Ecole Normale
supérieure Paris-Saclay, CNRS, Centre Borelli; and Psychiatry Department, EPS
Barthélémy Durand, Etampes, France. 16Institute of Medical Psychology and
Medical Sociology, University Medical Center Schleswig Holstein, Kiel
University, Kiel, Germany. 17Department of Child and Adolescent Psychiatry
Tschorn et al. Translational Psychiatry          (2021) 11:157 Page 9 of 11
and Psychotherapy, University Medical Centre Göttingen, von-Siebold-Str. 5,
37075 Göttingen, Germany. 18Department of Psychiatry and Neuroimaging
Center, Technische Universität Dresden, Dresden, Germany. 19Department of
Psychiatry and Psychotherapy CCM, Charité – Universitätsmedizin Berlin,
corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin,
and Berlin Institute of Health, Berlin, Germany. 20School of Psychology and
Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland. 21PONS
Research Group, Dept of Psychiatry and Psychotherapy, Campus Charite Mitte,
Humboldt University, Berlin and Leibniz Institute for Neurobiology,
Magdeburg, Germany, and Institute for Science and Technology of Brain-
inspired Intelligence (ISTBI), Fudan University, Shanghai, PR China
Funding
Open Access funding enabled and organized by Projekt DEAL.
Conflict of interest
T.B. served in an advisory or consultancy role for ADHD digital, Infectophar,
Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH, Roche, and
Takeda. He received conference support or speaker’s fee by Medice and
TakedaShire. He received royalties from Hogrefe, Kohlhammer, CIP Medien,
Oxford University Press. The present work is unrelated to the above grants and
relationships. L.P. served in an advisory or consultancy role for Roche and
Viforpharm and received speaker’s fee by Shire. She received royalties from
Hogrefe, Kohlhammer and Schattauer. The present work is unrelated to the
above grants and relationships. The other authors report no biomedical
financial interests or potential conflicts of interest.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Received: 15 September 2020 Revised: 21 December 2020 Accepted: 28
January 2021
References
1. Swendsen, J. et al. Use and abuse of alcohol and illicit drugs in US adolescents.
Arch. Gen. Psychiatry 69, 390–398 (2012).
2. Merikangas, K. R. et al. Lifetime prevalence of mental disorders in US ado-
lescents: results from the National Comorbidity Study-Adolescent Supplement
(NCS-A). J. Am. Acad. Child Adolesc. Psychiatry 49, 980–989 (2010).
3. Stolle, M., Sack, P.-M. & Thomasius, R. Binge drinking in childhood and ado-
lescence. Dtsch Arztebl Int. 106, 323–328 (2009).
4. Sartor, C. E. et al. Progression from first drink, first intoxication and regular
drinking to alcohol use disorder: a comparison of African American and
European American youth. Alcohol Clin. Exp. Res. 40, 1515–1523 (2016).
5. Grant, J. D. et al. Adolescent alcohol use is a risk factor for adult alcohol and
drug dependence: evidence from a twin design. Psychological Med. 36,
109–118 (2006).
6. Hamburger, M. E., Leeb, R. T. & Swahn, M. H. Childhood maltreatment and
early alcohol use among high-risk adolescents. J. Stud. Alcohol Drugs 69,
291–295 (2008).
7. Castellanos-Ryan, N. et al. Neural and cognitive correlates of the common and
specific variance across externalizing problems in young adolescence. Am. J.
Psychiatry 171, 1310–1319 (2014).
8. Nees, F. et al. Determinants of early alcohol use in healthy adolescents: the
differential contribution of neuroimaging and psychological factors. Neu-
ropsychopharmacology 37, 986–995 (2012).
9. Robbins, T. W., Gillan, C. M., Smith, D. G., de Wit, S. & Ersche, K. D. Neuro-
cognitive endophenotypes of impulsivity and compulsivity: towards dimen-
sional psychiatry. Trends Cogn. Sci. 16, 81–91 (2012).
10. Samek, D. R., Keyes, M. A., Iacono, W. G. & McGue, M. Peer deviance, alcohol
expectancies, and adolescent alcohol use: explaining shared and nonshared
environmental effects using an adoptive sibling pair design. Behav. Genet. 43,
286–296 (2013).
11. Wichers, M., Gillespie, N. A. & Kendler, K. S. Genetic and environmental pre-
dictors of latent trajectories of alcohol use from adolescence to adulthood: a
male twin study. Alcohol. Clin. Exp. Res. 37, 498–506 (2013).
12. Li, J. J. et al. Polygenic risk, personality dimensions, and adolescent alcohol use
problems: a longitudinal study. J. Stud. Alcohol Drugs 78, 442–451 (2017).
13. Rietschel, M. & Treutlein, J. The genetics of alcohol dependence. Ann. N. Y.
Acad. Sci. 1282, 39–70 (2013).
14. Russell, M., Cooper, M. L. & Frone, M. R. The influence of sociodemographic
characteristics on familial alcohol problems: data from a community sample.
Alcohol Clin. Exp. Res. 14, 221–226 (1990).
15. Sher, K. J., Walitzer, K. S., Wood, P. K. & Brent, E. E. Characteristics of children of
alcoholics: putative risk factors, substance use and abuse, and psychopathol-
ogy. J. Abnorm. Psychol. 100, 427 (1991).
16. Schuckit, M. A. & Smith, T. L. An 8-year followup of 450 sons of alcoholic and
control subjects. Arch. Gen. Psychiatry 53, 202–210 (1996).
17. Hill, S. Y., Shen, S., Lowers, L. & Locke, J. Factors predicting the onset of
adolescent drinking in families at high risk for developing alcoholism. Biol.
Psychiatry 48, 265–275 (2000).
18. Lieb, R. et al. Parental alcohol use disorders and alcohol use and disorders in
offspring: a community study. Psychol. Med. 32, 63–78 (2002).
19. Müller, K. U. et al. No differences in ventral striatum responsivity between
adolescents with a positive family history of alcoholism and controls. Addiction
Biol. 20, 534–545 (2015).
20. Andrews, M. M. et al. Individuals family history positive for alcoholism show
functional magnetic resonance imaging differences in reward sensitivity that
are related to impulsivity factors. Biol. Psychiatry 69, 675–683 (2011).
21. Edwards, A. C. et al. The rate of change in alcohol misuse across adolescence is
heritable. Alcohol. Clin. Exp. Res. 41, 57–64 (2017).
22. Kendler, K. S., Gardner, C. & Dick, D. M. Predicting alcohol consumption in
adolescence from alcohol-specific and general externalizing genetic risk fac-
tors, key environmental exposures and their interaction. Psychol. Med. 41,
1507–1516 (2011).
23. Whelan, R. et al. Neuropsychosocial profiles of current and future adolescent
alcohol misusers. Nature 512, 185–189 (2014).
24. Heinrich, A. et al. Prediction of alcohol drinking in adolescents: personality-
traits, behavior, brain responses, and genetic variations in the context of
reward sensitivity. Biol. Psychol. 118, 79–87 (2016).
25. Harrell, Z. A. T., Slane, J. D. & Klump, K. L. Predictors of alcohol problems in
college women: the role of depressive symptoms, disordered eating, and
family history of alcoholism. Addictive Behav. 34, 252–257 (2009).
26. Haeny, A. M. et al. The association of impulsivity and family history of alcohol
use disorder on alcohol use and consequences. Alcohol. Clin. Exp. Res. 44,
159–167 (2020).
27. Kreek, M. J., Nielsen, D. A., Butelman, E. R. & LaForge, K. S. Genetic influences on
impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and
addiction. Nat. Neurosci. 8, 1450–1457 (2005).
28. Schumann, G. et al. The IMAGEN study: reinforcement-related behaviour in
normal brain function and psychopathology. Mol. Psychiatry 15, 1128–1139
(2010).
29. Knutson, B., Adams, C. M., Fong, G. W. & Hommer, D. Anticipation of increasing
monetary reward selectively recruits nucleus accumbens. J. Neurosci. 21,
RC159–RC159 (2001).
30. Lorenz, R. C. et al. Reward anticipation in the adolescent and aging brain. Hum.
Brain Mapp. 35, 5153–5165 (2014).
31. Rubia, K., Smith, A. B., Taylor, E. & Brammer, M. Linear age-correlated functional
development of right inferior fronto-striato-cerebellar networks during
response inhibition and anterior cingulate during error-related processes.
Hum. Brain Mapp. 28, 1163–1177 (2007).
32. Rubia, K., Smith, A. B., Brammer, M. J., Toone, B. & Taylor, E. Abnormal brain
activation during inhibition and error detection in medication-naive adoles-
cents With ADHD. AJP 162, 1067–1075 (2005).
33. Tzourio-Mazoyer, N. et al. Automated anatomical labeling of activations in
SPM using a macroscopic anatomical parcellation of the MNI MRI single-
subject brain. NeuroImage 15, 273–289 (2002).
34. Whelan, R. et al. Adolescent impulsivity phenotypes characterized by distinct
brain networks. Nat. Neurosci. 15, 920–925 (2012).
35. Costa, P. T. Jr & McCrae, R. R. Domains and facets: hierarchical personality
assessment using the Revised NEO Personality Inventory. J. Personal. Assess. 64,
21–50 (1995).
36. Woicik, P. A., Stewart, S. H., Pihl, R. O. & Conrod, P. J. The Substance Use Risk
Profile Scale: a scale measuring traits linked to reinforcement-specific sub-
stance use profiles. Addictive Behav. 34, 1042–1055 (2009).
37. Cloninger C. R. The temperament and character inventory-revised. (Center for
Psychobiology of Personality, Washington University, 1999).
Tschorn et al. Translational Psychiatry          (2021) 11:157 Page 10 of 11
38. Wechsler D. Wechsler Intelligence Scale for Children 4th Edition,(WISC—IV).
(The Psychological Corporation: A Harcourt Assessment Company, 2003).
39. Kirby, K. N., Petry, N. M. & Bickel, W. K. Heroin addicts have higher discount
rates for delayed rewards than non-drug-using controls. J. Exp. Psychol. General.
128, 78 (1999).
40. Newcomb, M. D., Huba, G. J. & Bentler, P. M. A multidimensional assessment of
stressful life events among adolescents: derivation and correlates. J. Health Soc.
Behav. 22, 400–415 (1981).
41. Schumann, G. et al. KLB is associated with alcohol drinking, and its gene
product β-Klotho is necessary for FGF21 regulation of alcohol preference. Proc.
Natl Acad. Sci. USA. 113, 14372–14377 (2016).
42. Hibell B., et al. The 1995 ESPAD report. (Alcohol and other drug use among
students in 26 European countiries, 1997).
43. Schmidt, A., Barry, K. L. & Fleming, M. F. Detection of problem drinkers: the
alcohol use disorders identification test (AUDIT). South. Med. J. 88, 52–59
(1995).
44. Selzer, M. L. The Michigan Alcoholism Screening Test: the quest for a new
diagnostic instrument. Am. J. Psychiatry 127, 1653–1658 (1971).
45. Skinner, H. A. The drug abuse screening test. Addictive Behav. 7, 363–371
(1982).
46. Pausova, Z. et al. Genes, maternal smoking, and the offspring brain and body
during adolescence: design of the Saguenay Youth Study. Hum. Brain Mapp.
28, 502–518 (2007).
47. Dager, A. D. et al. Influence of alcohol use and family history of alcoholism on
neural response to alcohol cues in college drinkers. Alcohol. Clin. Exp. Res. 37,
E161–E171 (2013).
IMAGEN Consortium
Trevor Robbins22, Jeffrey Dalley22, Naresh Subramaniam22, David Theobald22, Karl Mann23, Christiane Bach5,
Maren Struve23, Tobias Banaschewski5, Herta Flor8,9, Marcella Rietschel23, Rainer Spanagel23, Frauke Nees5,8,21,
Mira Fauth-Bühler23, Sabina Millenet5, Yvonne Grimmer23, Luise Poustka17, Mark Lathrop24, Andreas Heinz19,
Lisa Albrecht19, Nikolay Ivanov19, Nicole Strache19, Michael Rapp1,19, Andreas Ströhle19, Jan Reuter19,
Jürgen Gallinat19, Henrik Walter19, Isabel Gemmeke19, Alexander Genauck19, Caroline Parchetka19,
Katharina Weiß19, Johann Kruschwitz19, Bianca Raffaelli19, Alev Isci19, Laura Daedelow19, Alexis Barbot25,
Benjamin Thyreau25, Yannick Schwartz25, Christophe Lalanne25, Vincent Frouin25,
Dimitri Papadopoulos Orfanos10,25, Antoine Grigis10,25, John Rogers26, James Ireland26, Dirk Lanzerath27,
Jianfeng Feng28, Jean-Luc Martinot14, Zuleima Bricaud14, Fanny Gollier Briand14, Hervé LemaÎtre29,
Ruben Miranda14, Eric Artiges15, Jessica Massicotte14, Marie-Laure Paillère Martinot30, Helene Vulser14,
Jani Pentillä30, Irina Filippi14, André Galinowski14, Pauline Bezivin14, Gunter Schumann2,7,21, Anna Cattrell2,
Tianye Jia2, Sylvane Desrivières2,7, Helen Werts2, Lauren Topper2, Laurence Reed2, Chris Andrew2,
Catherine Mallik2, Barbara Ruggeri2, Charlotte Nymberg2, Gareth Barker2,7, Patricia J. Conrod2, Lindsay Smith2,
Eva Loth2, Stephanie Havatzias2, Sheyda Shekarrizi2, Emily Kitson2, Alice Robinson2, Deborah Hall2,
Chiara Rubino2, Hannah Wright2, Kerstin Stueber2, Eanna Hanratty2, Eleanor Kennedy2,
Fabiana Mesquita de Carvahlo2, Argyris Stringaris2, Gabriel Robert2, Alex Ing2, Christine Macare2, Bing Xu2,
Tao Yu2, Erin Burke Quinlan2,7, Patrick Constant31, Semiha Aydin13, Ruediger Brühl13, Albrecht Ihlenfeld13,
Bernadeta Walaszek13, Bernd Ittermann13, Michael Smolka18, Thomas Hübner18, Kathrin Müller18,
Stephan Ripke18, Sarah Jurk18, Eva Mennigen18, Dirk Schmidt18, Nora Vetter18, Veronika Ziesch18,
Juliane H. Fröhner18, Hugh Garavan11,32, Arun L. W. Bokde6,32, Robert Whelan19,32, Daniel Carter32, Emily Walsh32,
Susanne O’Driscoll32, Maria Leonora Fatimah Agan32, Mairead McMorrow32, Sinead Nugent32, Colm Connolly32,
Eoin Dooley32, Clodagh Cremen32, Jennifer Jones33, John O’Keefe33, Martin O’Connor33, Jean-Baptiste Poline34,
Christian Büchel35, Uli Bromberg35, Tahmine Fadai35, Juliana Yacubian35, Sophia Schneider35,
Maria Lobatchewa35, Claire Lawrence36, Craig Newman36, Kay Head36, Nadja Heym36, Penny Gowland12,36,
Alicia Stedman36, Mehri Kaviani36, Susannah Taplin36, Dai Stephens37, Tomáš Paus38, Zdenka Pausova38 and
Amir Tahmasebi38
22Behavioural and Clinical Neuroscience Institute, Cambridge University, Cambridge, UK. 23Central Institute of Mental Health, Mannheim, Germany. 24Centre
National de Génotypage, Genoscope, Èvry, France. 25Comissariat à l’Energie Atomique, Fontenay-aux-Roses, France. 26Delosis, Twickenham, UK. 27Deutsches
Referenzzentrum für Ethik, Bonn, Germany. 28Fudan University, Shanghai, China and Warwick University, Coventry, UK. 29Group d’Imagerie Neurofonctionelle,
Institut de Maladies Neurodégénératives, CNRS UMR 5293, Université de Bordeaux, Centre Broca Nouvelle-Aquitaine, Bordeaux, France. 30Institut National de la
Santé et de la Recherche Médicale, INSERM U1299 “Trajectoires développementales & psychiatrie”, University Paris Saclay, Ecole Normale supérieure Paris-Saclay,
CNRS, Centre Borelli and AP-HP.Sorbonne Université, Department of Child and Adolescent Psychiatry, Pitié-Salpêtrière Hospital, Paris, France. 31Pertimm, Paris,
France. 32Trinity College Dublin, Dublin, Ireland. 33University College Dublin, Dublin, Ireland. 34McGill University, Montréal, Canada and University of California,
Berkeley, USA. 35University Medical Centre Hamburg-Eppendorf, Hamburg, Germany. 36University of Nottingham, University Park, Nottingham, UK. 37University of
Sussex, Brighton, UK. 38University of Toronto, Toronto, ON, Canada
Tschorn et al. Translational Psychiatry          (2021) 11:157 Page 11 of 11
